SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 77 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $96,986 | -27.4% | 21,697 | +21.5% | 0.00% | 0.0% |
| Q1 2021 | $133,533 | -28.8% | 17,852 | +3.3% | 0.00% | -50.0% |
| Q4 2020 | $187,575 | +22.7% | 17,288 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $152,826 | -17.1% | 17,288 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $184,290 | +79.8% | 17,288 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $102,518 | -46.2% | 17,288 | -5.9% | 0.00% | -50.0% |
| Q3 2019 | $190,670 | +22.1% | 18,369 | +40.1% | 0.00% | 0.0% |
| Q3 2018 | $156,116 | +16.5% | 13,108 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $134,000 | – | 13,108 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,726,603 | $15,228,000 | 10.06% |
| Flagship Pioneering Inc. | 3,204,437 | $29,673,000 | 1.28% |
| Redmile Group, LLC | 3,620,376 | $33,525,000 | 0.95% |
| ARK Investment Management | 3,791,756 | $35,112,000 | 0.88% |
| Nikko Asset Management Americas, Inc. | 2,987,763 | $27,667,000 | 0.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,268,946 | $11,750,000 | 0.42% |
| 683 Capital Management, LLC | 429,775 | $3,980,000 | 0.36% |
| EcoR1 Capital, LLC | 248,480 | $2,301,000 | 0.23% |
| ALGERT GLOBAL LLC | 17,920 | $166,000 | 0.06% |
| Baker Brothers Advisors | 974,835 | $9,027,000 | 0.06% |